Scientific Advisory Board
The Lymphoma Research Foundation’s Scientific Advisory Board (SAB) comprises 45 world-renowned lymphoma experts, who seek out the most innovative and promising lymphoma research projects for support. Members of the Foundation’s SAB are leaders in blood cancer research, with outstanding experience and accomplishments in both lymphoma-specific research and clinical care. They guide the planning of LRF’s research program, selecting and monitoring grant recipients.
ANDREW D. ZELENETZ, MD, PhD
Chair
Memorial Sloan Kettering Cancer Center, New York
Andrew D. Zelenetz, MD, PhD, is the Medical Director of Quality Informatics at Memorial Sloan Kettering Cancer Center in New York. Prior to that, he had held the positions of Vice Chair, Medical Informatics from January 2013 to May 2016 and Chief, Lymphoma Service in the Division of Hematology/Oncology at MSKCC from 1994-December 2012. He is also a Professor of Medicine at Weill Cornell Medical College. Dr. Zelenetz was elected Chair-Elect of the SAB in 2017, assuming the Chair in 2019.
He has helped develop several agents now approved to treat lymphoma — including 131I-tosituomab/tositumomab, bortezomib, and pralatrexate — and through clinical studies he is evaluating the benefits of novel combinations of agents. Dr. Zelenetz has also published more than 100 papers on lymphoma research in journals such as Blood, Journal of Clinical Oncology and Clinical Cancer Research.
SONALI M. SMITH MD
Chair-Elect
The University of Chicago
RANJANA ADVANI, MD
Stanford University School of Medicine
ASH A. ALIZADEH, MD, PhD
Stanford University School of Medicine
STEPHEN ANSELL, MD, PhD
Mayo Clinic, Rochester
KRISTIE A. BLUM, MD
Winship Cancer Institute of Emory University
CATHERINE BOLLARD, MD, MBChB
George Washington University
Children’s National Medical Center
JENNIFER BROWN, MD
Dana-Farber Cancer Institute
JAMES R. CERHAN, MD, PhD
Mayo Clinic, Rochester
ETHEL CESARMAN, MD, PhD
NewYork-Presbyterian Hospital
Weill Cornell Medicine
BRUCE D. CHESON, MD, FACP, FAAAS, FASCO
Past Chair, 2010-2012
MORTON COLEMAN, MD
Chair, Medical Affiliates Board
NewYork-Presbyterian Hospital
Weill Cornell Medicine
SANDEEP DAVE, MD, MS
Duke University
KIERON M. DUNLEAVY, MD
George Washington University
GW Cancer Center
KOJO S.J. ELENITOBA-JOHNSON, MD
University of Pennsylvania
Perelman School of Medicine
ANDREW M. EVENS, DO, MSc, FACP
Rutgers Cancer Institute of New Jersey
CHRISTOPHER R. FLOWERS, MD, MS
The University of Texas MD Anderson Cancer Center
JONATHAN W. FRIEDBERG, MD, MMSc
University of Rochester
James P. Wilmot Cancer Institute
LEO I. GORDON, MD, FACP
Past Chair, 2015-2017
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
THOMAS M. HABERMANN, MD
Immediate Past Chair, 2017-2019
Mayo Clinic, Rochester
STEVEN M. HORWITZ, MD
Memorial Sloan Kettering Cancer Center
ERIC D. HSI, MD
Cleveland Clinic
BRAD S. KAHL, MD
Washington University School of Medicine
KARA KELLY, MD
Roswell Park Comprehensive Cancer Center
University at Buffalo Jacobs School of Medicine
ANN S. LACASCE, MD
Harvard Medical School
Dana-Farber Cancer Institute
JOHN P. LEONARD, MD
Past Chair, 2012-2015
NewYork-Presbyterian Hospital
Weill Cornell Medicine
BRIAN K. LINK, MD
University of Iowa
IZIDORE S. LOSSOS, MD
University of Miami Health System
Sylvester Comprehensive Cancer Center
PETER MARTIN, MD
Weill Cornell Medicine
ARI MELNICK, MD
NewYork-Presbyterian Hospital
Weill Cornell Medicine
LINDSAY M. MORTON, PhD
National Cancer Institute
LAURA PASQUALUCCI, MD
Columbia University
H. Irving Comprehensive Cancer Center
BARBARA PRO, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
KANTI R. RAI, MD, BS
Hofstra Northwell School of Medicine
LISA RIMSZA, MD
Mayo Clinic, Arizona
KERRY SAVAGE, MD
BC Cancer, Vancouver
DAVID SCOTT, MBChB, PhD
BC Cancer, Vancouver
LAURIE SEHN, MD, MPH
BC Cancer, Vancouver
MARGARET SHIPP, MD
Harvard Medical School
Dana-Farber Cancer Institute
EDUARDO M. SOTOMAYOR, MD
CHRISTIAN STEIDL, MD
BC Cancer, Vancouver
JOHN M. TIMMERMAN
UCLA Jonsson Comprehensive Cancer Center
SVEN de VOS, MD, PhD
UCLA Jonsson Comprehensive Cancer Center
HANS-GUIDO WENDEL, MD
Memorial Sloan Kettering Cancer Center
MICHAEL E. WILLIAMS, MD, ScM
University of Virginia Cancer Center
Members Emeritus
JOSEPH R. BERTINO, MD
Founding Chair
Rutgers Robert Wood Johnson Medical School
Rutgers Cancer Institute of New Jersey
